Âé¶¹´«Ã½

    Advertisement
    Evening Standard13:11Mounjaro Ozempic
    MailOnline20:25Mounjaro Ozempic
    Clinical Trials Arena06:13FDA Pharma Biotechnology
    RTT News06:32FDA Pharma Biotechnology
    Science Blog (Weblog)11:07Obesity Global Health Mounjaro
    The Independent01:41Obesity Global Health Mounjaro
    Aberdeen Live10:43Scotland Global Health
    The Mirror05:52Scotland Global Health
    Pharmacy Times14:14Canada Pharma Health
    MailOnline06:31
    Metro.co.uk17:36
    ScienceAlert11:02Ozempic Global Health
    Pharmacy Times13:13Obesity Health Pharma
    Yahoo! UK & Ireland01:55Ozempic Mounjaro Global Health
    Glasgow Evening Times06:11Ozempic Mounjaro Global Health
    In the last 8 hours
    The Economic Times20:15 30-Jul-25
    Yesterday
    American Journal of Managed Care09:08 30-Jul-25
    Pharmaceutical Technology07:37 30-Jul-25
    WIRED05:13 30-Jul-25
    In the last 7 days
    Rock Hill Herald17:19 29-Jul-25
    American Journal of Managed Care17:12 29-Jul-25
    Benzinga13:35 29-Jul-25
    Journal of American Medical Associations11:15 29-Jul-25
    Evening Standard10:40 29-Jul-25
    Yahoo! UK & Ireland10:26 29-Jul-25
    Yahoo! US09:41 29-Jul-25
    pharmaphorum09:06 29-Jul-25
    Clinical Trials Arena06:13 29-Jul-25
    Vizient (Press Release)05:01 29-Jul-25
    American Journal of Managed Care22:44 28-Jul-25
    American Journal of Managed Care17:48 28-Jul-25
    PBS Online17:43 28-Jul-25
    Fox News15:19 28-Jul-25
    The Economic Times15:12 28-Jul-25
    Pharmacy Times14:14 28-Jul-25
    Dazed Digital08:24 28-Jul-25
    RTT News06:32 28-Jul-25
    PR Newswire (Press Release)06:02 28-Jul-25
    News-Medical.Net00:23 28-Jul-25
    PR Newswire (Press Release)20:22 27-Jul-25
    Mint04:42 27-Jul-25
    Dibesity23:04 26-Jul-25
    MailOnline20:25 26-Jul-25
    The Motley Fool11:35 26-Jul-25
    The Scottish Herald02:53 26-Jul-25
    Dibesity22:16 25-Jul-25
    FOX13 Seattle16:47 25-Jul-25
    Benzinga14:50 25-Jul-25
    Charlottesville Daily Progress, Virginia13:39 25-Jul-25
    Tyla12:52 25-Jul-25
    Pharmacy Times12:16 25-Jul-25
    ScienceAlert11:02 25-Jul-25
    Aberdeen Live10:43 25-Jul-25
    EasternEye07:12 25-Jul-25
    McGill Office for Science and Society06:02 25-Jul-25
    The Mirror05:52 25-Jul-25
    Glasgow Evening Times05:51 25-Jul-25
    Knowridge Science Report20:29 24-Jul-25
    The Irish News19:18 24-Jul-25
    The Independent19:03 24-Jul-25
    Dibesity14:24 24-Jul-25
    Health Magazine13:43 24-Jul-25
    Benzinga11:37 24-Jul-25
    Tyla09:31 24-Jul-25
    Science News Online09:02 24-Jul-25
    Pharmaceutical Technology08:26 24-Jul-25
    British Medical Journal05:43 24-Jul-25
    The Motley Fool01:57 24-Jul-25
    In the last month
    Medpage Today17:15 23-Jul-25
    News-Medical.Net14:33 23-Jul-25
    LADbible13:46 23-Jul-25
    Pharmacy Times12:07 23-Jul-25
    Mint11:25 23-Jul-25
    Science Blog (Weblog)11:07 23-Jul-25
    Zacks10:55 23-Jul-25
    Vogue08:04 23-Jul-25
    The Cut07:13 23-Jul-25
    Knowridge Science Report06:59 23-Jul-25
    Korea Biomedical Review06:21 23-Jul-25
    News-Medical.Net23:06 22-Jul-25
    The Hindu22:39 22-Jul-25
    Knowridge Science Report20:28 22-Jul-25
    Oprah Daily17:15 22-Jul-25
    National Law Review16:24 22-Jul-25
    Evening Standard13:11 22-Jul-25
    Tyla11:40 22-Jul-25
    Daily Sabah08:17 22-Jul-25
    PR Newswire (Press Release)08:02 22-Jul-25
    LADbible07:03 22-Jul-25
    EasternEye06:18 22-Jul-25
    The Star, Kenya04:51 22-Jul-25
    The Economic Times03:22 22-Jul-25
    Manufacturing Chemist02:04 22-Jul-25
    The Independent01:41 22-Jul-25
    News-Medical.Net00:42 22-Jul-25
    Kelowna Capital News19:24 21-Jul-25
    LADbible15:55 21-Jul-25
    Study Finds15:24 21-Jul-25
    The Nittany Turkey (Weblog)14:17 21-Jul-25
    TCTMD13:34 21-Jul-25
    Pharmacy Times13:13 21-Jul-25
    Wellbeing News11:50 21-Jul-25
    Business Wire (Press Release)11:05 21-Jul-25
    Business Wire (Press Release)11:05 21-Jul-25
    Tyla10:59 21-Jul-25
    The Seattle Times09:10 21-Jul-25
    PR Newswire (Press Release)09:03 21-Jul-25
    Business Wire (Press Release)08:01 21-Jul-25
    British Medical Journal07:01 21-Jul-25
    MailOnline06:11 21-Jul-25
    LADbible12:34 20-Jul-25
    The Business Standard01:28 20-Jul-25
    Metro.co.uk17:36 19-Jul-25
    MailOnline15:31 19-Jul-25
    MailOnline06:31 19-Jul-25
    Knowridge Science Report06:26 19-Jul-25
    The Independent01:00 19-Jul-25
    The Telegraph, Calcutta22:40 18-Jul-25
    The Mirror19:37 18-Jul-25
    People18:47 18-Jul-25
    Victoria Buzz18:11 18-Jul-25
    Business Wire (Press Release)16:18 18-Jul-25
    American Journal of Managed Care15:30 18-Jul-25
    The Mirror14:38 18-Jul-25
    The Economic Times13:57 18-Jul-25
    Zacks10:46 18-Jul-25
    Macdonald-Laurier Institute10:40 18-Jul-25
    Pharmacy Times10:07 18-Jul-25
    Pharmacy Times09:57 18-Jul-25
    Knowridge Science Report06:30 18-Jul-25
    view more headlines
    30 Jul 20:15

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.